New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
07:39 EDTGMEDGlobus Medical risk/reward favorable at current levels, says Leerink
Leerink believes the recent pullback in shares of Globus Medical brings a favorable risk/reward profile and long-term buying opportunity. The firm reiterates an Outperform rating on the name.
News For GMED From The Last 14 Days
Check below for free stories on GMED the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 11, 2014
07:19 EDTGMEDGlobus Medical reiterated as top pick at Piper Jaffray
Piper Jaffray reiterates Globus Medical as a top pick and raised its price target for shares to $28 from $26. Piper views the stock's valuation as among the most compelling in its coverage universe. It believes Globus' underlying business is solid and reiterates an Overweight rating on the stock. JMP Securities this morning initiated Globus Medical with an Outperform rating and $25 price target.
06:24 EDTGMEDGlobus Medical initiated with an Outperform at JMP Securities
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use